Suboptimal lopinavir exposure in infants 1-12 months on rifampicin treatment receiving double-dosed or semi-superboosted lopinavir/ritonavir; Results from the EMPIRICAL trial

Category Primary study
ConferenceAIDS 2022 - the 24th International AIDS Conference
Year 2022
This article has no abstract
Epistemonikos ID: 0a79edffb973d7ac9b413eaadbdfe25b80acab9e
First added on: Jan 10, 2026